| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |